Page 4 - Initiating Coverage News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Coverage Initiated on Company with Genuine Physiological Heart Replacement Therapy
streetwisereports.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetwisereports.com Daily Mail and Mail on Sunday newspapers.
Coverage Initiated on New Iberian Pyrite Belt Zinc-Focused Company
streetwisereports.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetwisereports.com Daily Mail and Mail on Sunday newspapers.
Route Mobile - Acquisition to help add marquee clients - ICICI Securities
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.
Research Report
Streetwise Reports (4/20/21) A CIBC World Markets initiation report states that MAG Silver Corp. offers attractive silver exposure as its metal composition consists of ~56% from silver, which is one of the highest in our coverage universe.
In an April 13 research note, CIBC World Markets Inc. research analyst Cosmos Chiu stated that the firm has initiated coverage of MAG Silver Corp. (MAG:TSX; MAG:NYSE A), an emerging Canada-based silver producer that owns a 44% interest in the high-grade Juanicipio mine located in Mexico s Fresnillo district. The analyst noted that MAG Silver s partner and operator at Juanicipio, Fresnillo Plc., is the world s largest primary silver producer.
Ajanta Pharma (Initiating Coverage) - Gearing for the next leap - HDFC Securities
Posted On:
Ms. Bansi Desai, Institutional Research Analyst, HDFC Securities
Ajanta Pharma is a diversified branded play with best-in-class return metrics. Its high exposure to branded generics markets (70%+ revenue from India, Asia and Africa) offers sustainable growth visibility with superior profitability. Rising scale in the US business is expected to drive margin expansion and increased contribution to the overall profits. With the conclusion of major capex cycle (Rs16bn+ in the past 6 years, internally funded) and plant opex reflecting in P&L, operating leverage benefits are expected to drive strong earnings growth of 18% CAGR, core-ROCE expansion of ~550bps to 28% and FCF generation of ~Rs13bn over FY21e-FY23e. Initiate with a BUY and target price of Rs2,150/sh.